Cyclerion Therapeutics (CYCN) Earnings Analysis
Cyclerion Therapeutics (CYCN) has no confirmed upcoming earnings date. Last quarter (2026-03-30) it beat with EPS -0.19 USD vs -0.38 USD est (+50%). It has beaten estimates in 2/2 recent quarters (100%). Trailing P/E -2.56.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does CYCN next report earnings?
No confirmed upcoming earnings date is currently scheduled for CYCN. This page updates as the calendar is published.
CYCN earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-03-30 | -0.19 USD | -0.38 USD | +50% | Beat |
| 2026-03-25 | -0.38 USD | -0.38 USD | 0% | Beat |
| 2025-03-04 | 0.22 USD | n/a | n/a | n/a |
| 2024-11-14 | -0.29 USD | n/a | n/a | n/a |
Beat rate: 2/2 (100%) over reported quarters with consensus data.
CYCN valuation and analyst view
| Trailing P/E | -2.56 |
|---|---|
| Trailing EPS | -1.2547 USD |
| Price / book | 2.25 |
| Dividend yield | 0.00% |
| Market cap | 0.02B |
| Analyst consensus | Buy (2 buy / 0 hold / 0 sell) |
Related research pages
Frequently asked questions
When is Cyclerion Therapeutics (CYCN)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for CYCN. This page updates as the calendar is published.
Did CYCN beat earnings last quarter?
In its 2026-03-30 report, CYCN posted EPS of -0.19 USD versus a -0.38 USD estimate — a beat of 50%.
What is CYCN's earnings track record?
Over the last 2 reported quarters with consensus data, CYCN beat estimates 2 times (100%).
What is CYCN's current P/E ratio and EPS?
CYCN trades at a trailing P/E of -2.56 on trailing EPS of -1.2546967895362664 USD.
What do analysts rate CYCN?
Analyst consensus is "Buy" across 2 ratings (0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell).